Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 6,300.00
-330.00 (-4.98%)
At close: May 29, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 81.56 billion as of June 1, 2026. Its market cap has decreased by -7.49% in one year.
Market Cap
81.56B
Enterprise Value
66.22B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6,300.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 81.56B, a decrease of -27.68%. That is a compound annual growth rate of -10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 81.56B | -32.91% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KOREA PHARMA | 102.96B |
| Organoidsciences | 97.27B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 91.75B |
| Sam-A Pharm. | 88.56B |
| Polaris AI Pharma | 84.88B |
| Daehan Nupharm | 83.93B |
| Sinsin Pharmaceutical | 76.46B |
| GL Pharm Tech | 74.06B |